Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Cascella Insider Profile
4 Followers
Robert Cascella, CEO & President, Director at Hologic, holds 541.99K shares in Neuronetics (Ticker: STIM), holds 70.98K shares in REPRO-MED Systems (Ticker: KRMD), holds 45.44K shares in Mirion Technologies (Ticker: MIR).
Robert Cascella Hologic (HOLX)CEO & President, Director
Hologic (HOLX)
CEO & President, Director
Ranked #1,167 out of 100,516 Corporate Insiders
Profitable Transactions
5 out of 7 Profitable Transactions
Average Return
+101.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert Cascella holds in companies
Most Profitable Insider Trade
The most profitable trade made by Robert Cascella
Robert Cascella's Trading History
Hologic
Jul 02, 2013
CEO & President, Director
Uninformative Sell
391.00K
$25.39M
Neuronetics
Feb 10, 2025
Director
Uninformative Buy
200.00K
$2.36M
Mirion Technologies
Jun 04, 2024
Director
Uninformative Buy
―
$740.69K
REPRO-MED Systems
Oct 01, 2024
Director
Uninformative Buy
15.00K
$310.17K
Celestica
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Robert Cascella's performance on stock
You May Also Like
Robert Cascella insider profile FAQ
What is the percentage of profitable transactions made by Robert Cascella?
The percentage of profitable transactions made by Robert Cascella is 71%.
What is the average return per transaction made by Robert Cascella?
The average return per transaction made by Robert Cascella is 101.70%.
What stocks does Robert Cascella hold?
Robert Cascella holds: HOLX, STIM, MIR, KRMD, CLS stocks.
What was Robert Cascella’s latest transaction?
Robert Cascella latest transaction was an Uninformative Buy of $200.00K.
What was Robert Cascella's most profitable transaction?
Robert Cascella’s most profitable transaction was an Informative Buy of STIM stock on September 13, 2024. The return on the trade was 319.90%.
What is Robert Cascella's role in Hologic?
Robert Cascella's role in Hologic is CEO & President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.